GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (FRA:25I) » Definitions » Other Assets for Banks

ImmuPharma (FRA:25I) Other Assets for Banks


View and export this data going back to 2017. Start your Free Trial

What is ImmuPharma Other Assets for Banks?

Other Assets (Bank) only applies to banks.


ImmuPharma Business Description

Traded in Other Exchanges
Address
One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease.